Publicaciones – Centro de Estudios e Investigación de la Enfermedad de Chagas y Leishmaniasis

Trabajos Publicados en los Últimos 5 Años

1. “Análisis de la función y ultraestructura mitocondrial en ratones albinos sanos tratados con medicamentos para insuficiencia cardíaca”. Camino Willhuber G, Guzmán Mentesana G, Baez A, Lo Presti S, Bazán C, Strauss M, Fretes R, Paglini-Oliva PA, Rivarola HW. Revista de la Facultad de Ciencias Médicas, 74: 230-238. 2017. ISSN 0014-6722.

2. “In vitro and in vivo drug combinations for the treatment of Trypanosoma cruzi infection: A multivariate approach”. Strauss M, da Silva Rodrigues JH, Lo Presti MS, Bazán PC, Báez AL, Miler NC, Bustamante JM, Paglini-Oliva PA, Nakamura CV, Rivarola HW. Experimental Parasitology, 189: 19-27. 2018.

3. “Differential tissue distribution of Trypanosoma cruzi during acute experimental infection: further evidence using natural isolates”. Strauss M, Velázquez López DA, Moya DM, Bazán PC, Báez AL, Rivarola HW, Paglini-Oliva PA, Lo Presti MS. Molecular and Biochemical Parasitology, 222: 29-33. 2018.

4.  Quantitative PCR and unconventional serological methods to evaluate clomipramine treatment effectiveness in experimental Trypanosoma cruzi infection. Bazán PC; Lo Presti MS, Strauss M, Báez AL, Miler N, Paglini PA, Rivarola HW.  Experimental and Molecular Pathology 101 (2016) 274–280

5. Mitochondrial dysfunction in skeletal muscle during experimental Chagas disease
Báez AL, Reynoso MN, Lo Presti MS, Bazán PC, Strauss M, Miler N, Pons P, Rivarola HW, Paglini-Oliva P. Exp Mol Pathol. 2015 Jun;98(3):467-75. doi: 10.1016/j.yexmp.2015.03.034. Epub 2015 Mar 31.

6. Trypanothione reductaseinhibitors: Overview of theaction of thioridazine in differentstages of Chagas disease.
Lo Presti MS, Bazán PC, Strauss M, Báez AL, Rivarola HW, Paglini-Oliva PA. Acta Trop. 2015 May;145:79-87. doi: 10.1016/j.actatropica.2015.02.012. Epub 2015 Feb 27. Review.

7. Functional and structuralalterations of cardiac and skeletalmusclemitochondria in heartfailurepatients.
Guzmán Mentesana G, Báez AL, Lo Presti MS, Domínguez R, Córdoba R, Bazán C, Strauss M, Fretes R, Rivarola HW, Paglini-Oliva P. ArchMed Res. 2014 Apr;45(3):237-46. doi: 10.1016/j.arcmed.2014.03.003. Epub 2014 Mar 21. PMID:

8. Circulating Trypanosoma cruzi populationsdifferfromthosefound in thetissues of thesame host duringacute experimental infection.
Lo Presti MS, Esteves BH, Moya D, Bazán PC, Strauss M, Báez AL, Pizzi R, Quispe Ricalde MA, Valladares B, Rivarola HW, Paglini-Oliva PA. Acta Trop. 2014 May;133:98-109. doi: 10.1016/j.actatropica.2014.02.010. Epub 2014 Feb 19. PMID:

9. Use of clomipramine as chemotherapy of thechronicphase of Chagas disease.
Fauro R, Lo Presti S, Bazan C, Baez A, Strauss M, Triquell F, Cremonezzi D, Negrete OS, Willhuber GC, Paglini-Oliva P, Rivarola HW. Parasitology. 2013 Jun;140(7):917-27. doi: 10.1017/S0031182013000103. Epub 2013 Mar 27. PMID:

10. Clomipramine and benznidazoleassociationforthetreatment of acute experimental Trypanosoma cruzi infection.
Strauss M, Lo Presti MS, Bazán PC, Baez A, Fauro R, Esteves B, Sanchez Negrete O, CremonezziD,Paglini-Oliva PA, Rivarola HW. ParasitolInt. 2013 Jun;62(3):293-9. doi: 10.1016/j.parint.2013.02.004. Epub 2013 Mar 14. PMID:

11. Chroni cindeterminatephase of Chagas’ disease: mitochondrialinvolvement in infection witht wostrains.
Báez AL, Lo Presti MS, Fretes R, Díaz C, Pons P, Bazán PC, Strauss M, Rivarola HW, Paglini-OlivaP. Parasitology. 2013 Mar;140(3):414-21. doi: 10.1017/S0031182012001771. Epub 2012 Nov 9.

12. Differential susceptibility of isolated humantrophoblasts to infectionbyTrypanosomacruzi. Díaz-Luján C, Triquell MF, Schijman A, PagliniP,Fretes. R.
Placenta 33: 264-270; 2012.

13. Chemicalcompositions and properties of Schinusareira L. essentialoilonairwayinflammation and cardiovascular system of mice and rabbits. Bigliani MC, Rossetti V, Grondona E, Presti SL, Paglini P, Rivero V, Zunino MP, Ponce AA. Food Chem Toxicol.50: 2282-2288; 2012.

14. Persistence of Trypanosoma cruzi in Experimental Chagasic Cardiomyopathy. Bazan C, Micucci l , Fauro R , Triquel M.F , Lo Presti M.S, Baez A, Strauss M, Camino G, Paglini-Oliva Patricia, Rivarola H.WAnti Infective Ag 10:136-141; 2012.

15. New insightsintopathophysiology and treatment in Chagas-Mazza disease. Rivarola HW, Paglini-OlivaP.
RevFac Cien MedUnivNacCordoba. 2011;68(4):154-63. Review. Spanish.

16. Role of mitochondria and reactive oxygenspecies in theprogression of heartfailure. GuzmanMentesana G, Baez A, Córdoba R, Dominguez R, Lo Presti S, Rivarola W, Pons P, Fretes R,Paglini-Oliva P.
RevFac Cien MedUnivNacCordoba. 2010;67(4):150-8. Spanish.

17. Relevance of biofilms in pediatrictonsillardisease. Diaz RR, Picciafuoco S, Paraje MG, Villegas NA, Miranda JA, Albesa I, Cremonezzi D, Commisso R,Paglini-Oliva P.
Eur J ClinMicrobiolInfectDis. 2011 Dec;30(12):1503-9. doi: 10.1007/s10096-011-1249-3. Epub 2011 Apr

18. Mitochondrial involvement in chronicchagasiccardiomyopathy. Báez A, Lo Presti MS, Rivarola HW, Mentesana GG, Pons P, Fretes R, Paglini-Oliva P.
Trans R SocTropMedHyg. 2011 May;105(5):239-46. doi: 10.1016/j.trstmh.2011.01.007. Epub 2011 Apr 5.

19. Importance of host sex in thedevelopment of trypanosoma cruzi infection. Micucci LR, Bazán PC, Fauro R, Baez A, Lo Presti MS, Triquel MF, Paglini-Oliva PA, Rivarola HW.
RevFac Cien MedUnivNacCordoba. 2010;67(2):73-6.

20. Association of clomipramine and allopurinolforthetreatment of the experimental infectionwith Trypanosoma cruzi. Gobbi P, Baez A, Lo Presti MS, Fernández AR, Enders JE, Fretes R, Gea S, Paglini-Oliva PA, Rivarola HW. Parasitol Res. 2010 Oct;107(5):1279-83. doi: 10.1007/s00436-010-2002-z. Epub 2010 Aug 3.


Capítulos de Libros

“Electrocardiography as a DiagnosticMethodfor Chagas Disease in Patients and Experimental Models”.   Patricia Paglini_Oliva, M Silvina Lo Prest and H Walter Rivarola. In Parasitology, In Tech, 2012 ISBN:978-953-51-0149-9

“Antidepressants Used as Chemotherapy for Trypanosoma cruzi Infection: Phenothiazines and Related Compounds” Paglini-Oliva P, Lo Presti MS, Rivarola HW. Frontiers in Anti-Infective Drug Discovery 4: 31-67, Bentham Science Publishers. ISBN: 978-1-60805-583-8.